Skip to main content
. 2020 Oct 20;14(1):100901. doi: 10.1016/j.tranon.2020.100901

Fig. 1.

Fig. 1

C-Score biomarkers predict the efficacy of chemotherapy in LAGC in both SRRSH and TCGA cohorts.

C-Score biomarkers were evaluated in both SRRSH and TCGA cohorts, Kaplan-Meier analysis indicated that high RRM1 (A), low RRM2 (B), low RRM2B (C), low POLH (D), high DUT (E), low TYMS (F), low KI67 (G) or low TYMP (H) were associated with better response to adjuvant chemotherapy compare to low RRM1, high RRM2, high RRM2B, high POLH, low DUT, high TYMS, high KI67 or high TYMP, respectively.